Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Venrock Healthcare Capital Partners III, L.P. reported a 8.20% stake in Cytomx Therapeutics, Inc. (Schedule 13G)
Event May 13, 2025 · Filed May 20, 2025
Venrock Healthcare Capital Partners III, L.P. reported a 8.20% stake in Cytomx Therapeutics, Inc., 12,992,500 shares, as a passive investor on May 13, 2025. Filed May 20, 2025 (Schedule 13G).
- Stake
- 8.20%
- Shares
- 12,992,500
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 8.20% | 12,992,500 |
| VHCP Co-Investment Holdings III, LLC | 8.20% | 12,992,500 |
| Venrock Healthcare Capital Partners EG, L.P. | 8.20% | 12,992,500 |
| VHCP Management III, LLC | 8.20% | 12,992,500 |
| VHCP Management EG, LLC | 8.20% | 12,992,500 |
| Nimish Shah | 8.20% | 12,992,500 |
| Bong Y Koh | 8.20% | 12,992,500 |
Source
Related
- Cytomx Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026